IBI3042

DRUG2 trials

Sponsors

Innovent Biologics (Suzhou) Co. Ltd., Hongwei Jiang

Conditions

Healthy ParticipantsHeathy ParticipantsObesityOverweight

Phase 1

IBI3042 Study in Healthy Participants and Overweight or Obese Participants

RecruitingNCT07793019

Innovent Biologics (Suzhou) Co. Ltd.Healthy Participants, Obesity, Overweight

Start: 2026-09-07End: 2028-01-26Target: 104Updated: 2026-09-11

An Exploratory Study of Single-Dose and Multiple-Doses IBI3042 in Healthy, Overweight, or Obese Participants

Not yet recruitingNCT07802899

Hongwei JiangHeathy Participants, Obesity, Overweight

Start: 2026-09-02End: 2027-05-02Target: 94Updated: 2026-09-03